Free shipping over €250 · Tracked, discreet delivery in Europe

UU library

Every peptide, mapped to the body.

160 compounds, from approved medicines to early research molecules. Each one filed by the system research looks at, with its regulatory status and the strength of the evidence behind it.

Explore the mapWhat UU carries
Compounds
160
Research summaries
39
At UU
56
  • Approved medicine71

    Approved as a medicine by the FDA or the EMA for at least one indication. Approval covers the named indication and formulation only.

  • In clinical trials19

    In human clinical trials and not yet approved by the FDA or the EMA. Results to date are from trial populations under medical supervision.

  • Research compound53

    Not approved as a medicine by the FDA or the EMA. Some are registered in individual countries. Supplied for laboratory research only.

  • Cosmetic ingredient17

    Used as a topical cosmetic ingredient. Cosmetic use is not a medicinal approval, and most evidence comes from manufacturer and small panel studies.

Reviewed October 2026

In the UU catalog

Researched, batch-tested, ready to ship.

Compounds UU carries that have a full research summary in the library.

16 compounds · Brain, mood & sleep

Brain, mood & sleep16

Peptides studied for cognition, stress response, sleep architecture and the nervous system.

Shop FOCUS
  • ApprovedAt UU

    Oxytocin

    Pitocin · Syntocinon

    Neurohypophyseal hormone

    The nine-residue hormone of labour and bonding. Approved to induce or support labour, and studied for social behaviour.

    Human trialsShop
  • ResearchAt UU

    ARA-290

    Cibinetide

    Erythropoietin-derived peptide

    A small peptide modelled on erythropoietin that does not raise red cell counts. Studied in early trials for small fibre neuropathy.

    Early human dataShop
  • ResearchAt UU

    Selank

    Tuftsin analogue

    A synthetic heptapeptide registered as an anxiolytic in Russia. Studied for anxiety, stress response and neuroimmune signalling.

    Early human dataShop
  • ResearchAt UU

    DSIP

    Delta sleep-inducing peptide

    Neuropeptide

    A nonapeptide first isolated in 1977 from the blood of sleeping rabbits. Studied for sleep architecture and stress hormones.

    Mixed evidenceShop
  • ResearchAt UU

    Semax

    ACTH(4-10) analogue

    A heptapeptide built on a fragment of ACTH, registered in Russia. Studied for stroke recovery, BDNF signalling and cognition.

    Mixed evidenceShop
  • ResearchAt UU

    Dihexa

    PNB-0408

    Angiotensin IV analogue

    A small molecule derived from angiotensin IV, studied in rodents for memory. Its founding paper carries a notice of concern and a key mechanism paper was retracted.

    PreclinicalShop
  • ResearchAt UU

    Epithalon

    Epitalon · Ala-Glu-Asp-Gly

    Pineal tetrapeptide

    A synthetic tetrapeptide derived from a pineal gland extract. Studied in cell and animal research on telomeres and ageing.

    PreclinicalShop
  • ResearchAt UU

    Pinealon

    Glu-Asp-Arg

    Short bioregulator peptide

    A tripeptide from St Petersburg bioregulator research. Studied in cell and animal models of neuroprotection and ageing.

    PreclinicalShop
  • ResearchAt UU

    Cortagen

    Short bioregulator peptide

    A synthetic tetrapeptide from Russian bioregulator research. Studied in animal models of nervous system recovery.

    Summary pendingShop
  • ResearchAt UU

    Normoftal

    Short bioregulator peptide

    A bioregulator peptide associated with retinal tissue in Russian research. The published literature is small and mostly preclinical.

    Summary pendingShop
  • ResearchAt UU

    P21

    P021

    CNTF-derived peptide

    A small peptide mimetic of ciliary neurotrophic factor. Studied in mouse models of neurogenesis and memory.

    Summary pendingShop
  • Research

    Cerebrolysin

    Porcine brain peptide mixture

    A mixture of low-molecular-weight peptides from pig brain, registered in several European and Asian countries but not by the FDA or the EMA. Studied after stroke and brain injury.

    Summary pending
  • Approved

    Glatiramer acetate

    Copaxone

    Random amino acid copolymer

    A mixture of polypeptides built from four amino acids. Approved for relapsing forms of multiple sclerosis.

    Summary pending
  • In trials

    NNZ-2591

    Cyclic glycine-proline analogue

    A synthetic analogue of a natural IGF-1 metabolite. In clinical trials for rare neurodevelopmental disorders.

    Summary pending
  • Approved

    Trofinetide

    Daybue

    IGF-1 tripeptide analogue

    A synthetic analogue of the N-terminal tripeptide of IGF-1. Approved by the FDA in 2023 for Rett syndrome.

    Summary pending
  • Approved

    Ziconotide

    Prialt

    N-type calcium channel blocker

    A synthetic form of a cone snail toxin. Approved for severe chronic pain, given into the spinal fluid.

    Summary pending

The UU library is an educational reference. It is not medical advice, does not make a health claim, and does not tell anyone how to use a compound. UU products are sold for laboratory research use only and are not for human consumption. Regulatory status changes: confirm it with the relevant authority before relying on it.